1. Lissa FC, Argente JS, Antunes GN, Basso Fde O, Furtado J. Maffucci syndrome and soft tissue sarcoma: a case report. Int Semin Surg Oncol. 2009; 6:2.
Article
2. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol. 2007; 56:541–64.
3. Biber C, Ergun P, Turay UY, Erdogan Y, Hizel SB. A case of Maffucci’s syndrome with pleural effusion: ten-year follow-up. Ann Acad Med Singap. 2004; 33:347–50.
Article
4. Verdegaal SH, Bovée JV, Pansuriya TC, et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011; 16:1771–9.
Article
5. Tsao YP, Tsai CY, Chen WS. Maffucci syndrome. J Rheumatol. 2015; 42:2434–5.
Article
6. Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011; 43:1262–5.
Article
7. Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H. Maffucci syndrome and neoplasms: a case report and review of the literature. BMC Res Notes. 2016; 9:126.
Article
8. Cheng P, Chen K, Zhang S, Mu KT, Liang S, Zhang Y. IDH1 R132C and ERC2 L309I mutations contribute to the development of Maffucci’s syndrome. Front Endocrinol (Lausanne). 2021; 12:763349.
Article
9. Wang D, Su L, Han Y, et al. Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: Initial results. Head Neck. 2017; 39:288–96.
Article
10. Silve C, Jüppner H. Ollier disease. Orphanet J Rare Dis. 2006; 1:37.
Article